Weight gain associated with antipsychotic drugs

Journal of Clinical Psychiatry

Volumn 60, Issue SUPPL. 21, 1999, Pages 20-24

  Ganguli, Rohan ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORDIAZEPOXIDE; CHLORPROMAZINE; CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; LOXAPINE; MESORIDAZINE; MOLINDONE; NEUROLEPTIC AGENT; OLANZAPINE; PHENOBARBITAL; PROMAZINE; QUETIAPINE; RISPERIDONE; THIORIDAZINE; TIOTIXENE; TRIFLUOPERAZINE;

DISEASE ASSOCIATION; DRUG EFFECT; HUMAN; OBESITY; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; WEIGHT GAIN;

ADMINISTRATION, ORAL; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLOZAPINE; DELAYED-ACTION PREPARATIONS; HUMANS; OBESITY; PIRENZEPINE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; WEIGHT GAIN;

EID: 0032717075     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Klett CJ, Caffey EM Jr. Weight changes during treatment with phenothiazine derivatives. J Neuropsychiatry 1960;2:102-108
2. Holden JMC, Holden UP. Weight changes with schizophrenic psychosis and psychotropic drug therapy. Psychosomatics 1970;11:551-561
3. Dufresne RL, Dominic V, Kaas DJ. Thioridazine improves affective symptoms in schizophrenic patients. Psychopharmacol Bull 1993;29:249-255
4. Doss FW. The effect of antipsychotic drugs on body weight: a retrospective review. J Clin Psychiatry 1979;40:528-530
5. Johnson DAW, Breen M. Weight changes with depot neuroleptic maintenance therapy. Acta Psychiatr Scand 1979;59:525-528
6. Planansky K, Heilizer F. Weight changes in relation to the characteristics of patients on chlorpromazine. J Clin Exp Psychopathol 1959;20:53-57
7. Leadbetter R, Shutty M, Pavalonis D, et al. Clozapine-induced weight gain: prevalence and clinical relevance. Am J Psychiatry 1992;149:68-72
8. Umbricht DSG, Pollack S, Kane JM. Clozapine and weight gain. J Clin Psychiatry 1994;55(9, suppl B):157-160
9. Bustillo JR, Buchanan RW, Irish D, et al. Differential effect of clozapine on weight: a controlled study. Am J Psychiatry 1996;153:817-819
10. Norris DL, Israelstam K. Clozapine (Leponex) overdosage [letter]. S Afr Med J 1975;49:385
11. Lamberti JS, Bellnier T, Schwarzkopf SB. Weight gain among schizophrenic patients treated with clozapine. Am J Psychiatry 1992;149: 689-690
12. Hummer M, Kemmler G, Kurz M, et al. Weight gain induced by clozapine. Eur Neuropsychopharmacol 1995;5:437-440
13. Nemeroff CB. Dosing the antipsychotic medication olanzapine. J Clin Psychiatry 1997;58(suppl 10):45-49
14. Allison DB, Mentore JL, Heo M, et al. Weight gain associated with conventional and newer antipsychotics. Eur Neuropsychopharmacol 1998;8(suppl 2):S216-S217
15. Gallant DM, Bishop G, Guerrero-Figueroa R. Molindone: a crossover evaluation of capsule and tablet formulations in severely ill schizophrenic patients. Curr Ther Res 1973;15:915-918
16. Clark ML, Huber WK, Sakata K, et al. Molindone in chronic schizophrenia. Clin Pharm Ther 1970;11:680-688
17. Gardos G, Cole JO. Weight reduction in schizophrenics by molindone. Am J Psychiatry 1977;134:302-304
18. Heikkinen H, Outakoski J, Merilainen V, et al. Molindone and weight loss [letter]. J Clin Psychiatry 1993;54:160-161